Abstract
Elevated levels of B-cell-activating factor of the tumor necrosis factor family (BAFF) have been implicated in the pathogenesis of autoimmune diseases in human. In this study, we have constructed a vector for the expression of a novel compact antibody composed of anti-BAFF single-chain antibody fragment (scFv) and the Fc region (the hinge region, CH2, and CH3 domains) of human IgG1 in Chinese hamster ovary cells. The scFv–Fc fusion protein, showing spontaneous Fc fragment-mediated homodimerization via disulfide bridges, was affinity-purified on protein A Sepharose from culture supernatant. The scFv–Fc antibody was demonstrated to retain high binding affinity to antigen and prolonged clearance time in blood and to possess some human IgG crystallizable fragment effector functions such as protein A binding and antibody-dependent cellular cytotoxicity. These results suggest that this recombinant antibody may have therapeutic applications in the therapy of autoimmune disorders mediated by BAFF.
Similar content being viewed by others
Abbreviations
- BLyS:
-
B lymphocyte stimulator
- BAFF:
-
B-cell activating factor belonging to the TNF family
- BSA:
-
Bovine serum albumin
- FBS:
-
Fetal bovine serum
- Ab:
-
Antibody
- TALL-1:
-
TNF- and ApoL-related leukocyte-expressed ligand 1
- THANK:
-
TNF homologue that activates apoptosis, nuclear factor-kB, and c-Jun NH2 terminal kinase
- TNF:
-
Tumor necrosis factor
- Fc:
-
Crystallizing fragment, consists of CH2 and CH3, glycosylation site, not antigen binding, but responsible for effector functions
- G418:
-
Neomycin
- VH:
-
Immunoglobulin heavy-chain variable region
- VL:
-
Immunoglobulin light-chain variable region
- CH2 and CH3:
-
Immunoglobulin heavy-chain constant regions 2 and 3
- HRP:
-
Horseradish peroxidase
- mAb:
-
Monoclonal antibody
- TBST:
-
Tris-buffered saline Tween-20
References
Schneider, P., Mackay, F., Steiner, V., Hofmann, K., Bodmer, J. L., Holler, N., et al. (1999). The Journal of Experimental Medicine, 189, 1747–1756. doi:10.1084/jem.189.11.1747.
Shu, H. B., Hu, W. H., & Johnson, H. (1999). Journal of Leukocyte Biology, 65, 680–683.
Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G. L., & Aggarwal, B. B. (1999). The Journal of Biological Chemistry, 274, 15978–15981. doi:10.1074/jbc.274.23.15978.
Moore, P. A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D. W., Feng, P., et al. (1999). Science, 285, 260–263. doi:10.1126/science.285.5425.260.
Tribouley, C., Wallroth, M., Chan, V., Paliard, X., Fang, E., Lamson, G., et al. (1999). The Journal of Biological Chemistry, 380, 1443–1447. doi:10.1515/BC.1999.186.
Melchers, F. (2003). Annals of the Rheumatic Diseases, 62, 225–227. doi:10.1136/ard.62.suppl_2.ii25.
Schneider, P., & Tschopp, J. (2003). Immunology Letters, 88, 57–62. doi:10.1016/S0165-2478(03)00050-6.
Mackay, J. F., & Browning, L. (2002). Nature Reviews. Immunology, 2, 465–475. doi:10.1038/nri844.
Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulgamorskaya, S., Dobles, M., et al. (2001). Science, 293, 2111–2114. doi:10.1126/science.1061964.
Ramanujam, M., & Davidson, A. (2004). Arthritis Research & Therapy, 6, 197–202. doi:10.1186/ar1222.
Cao, P., Xia, Z., Song, W., & Zhang, S. (2005). Immunology Letters, 101, 87–94. doi:10.1016/j.imlet.2005.05.001.
Adams, G. P., Schier, R., Marshall, K., Wolf, E. J., McCall, A. M., Marks, J. D., et al. (1998). Cancer Research, 58, 485–490.
Persic, L., Roberts, A., Wilton, J., Cattaneo, A., Bradbury, A., & Hoogenboom, H. R. (1997). Gene, 187, 9–18. doi:10.1016/S0378-1119(96)00628-2.
Powers, D. B., Amersdorfer, P., Poul, M. A., Nielsen, U. B., Shalaby, M. R., Adams, G. P., et al. (2001). Journal of Immunological Methods, 251, 123–135. doi:10.1016/S0022-1759(00)00290-8.
Kaufman, R. J., Wasley, L. C., Spiliotes, A. J., Gossels, S. D., Latt, S. A., Larsen, G. R., et al. (1985). Molecular and Cellular Biology, 5, 1750–1759.
Kim, S. J., Kim, N. S., Ryu, C. J., Hong, H. J., & Lee, G. M. (1998). Biotechnology and Bioengineering, 58, 73–84. doi:10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R.
Wurm, F. M., Pallavicini, M. G., & Arathoon, R. (1992). Developments in Biological Standardization, 76, 69–82.
Omasa, T. (2002). Journal of Bioscience and Bioengineering, 94(6), 600–605.
Yoshikawa, T., Nakanishi, F., Ogura, Y., Oi, D., Omasa, T., Katakura, Y., et al. (2000). Biotechnology Progress, 16(5), 710–715. doi:10.1021/bp000114e.
Pelletier, M. R., Hatada, E. N., Scholz, G., & Scheidereit, C. (1997). Nucleic Acids Research, 25, 3995–4003. doi:10.1093/nar/25.20.3995.
Cao, P., Mei, J. J., Diao, Z. Y., & Zhang, S. Q. (2005). Protein Expression and Purification, 41, 199–206. doi:10.1016/j.pep.2005.01.001.
Nardelli, B., Belvedere, O., Roschke, V., Moore, P. A., Olsen, H. S., Migone, T. S., et al. (2001). Blood, 97, 198–204. doi:10.1182/blood.V97.1.198.
Cao, P., Tang, X. M., Guan, Z. B., Diao, Z. Y., & Zhang, S. Q. (2005). Protein Expression and Purification, 43, 157–164. doi:10.1016/j.pep.2005.04.022.
Friguet, B., Chaffotte, A. F., Djavadi-Ohaniance, L., & Goldberg, M. E. (1985). Journal of Immunological Methods, 77, 305–319. doi:10.1016/0022-1759(85)90044-4.
Ono, K., Kamihira, M., Kuga, Y., Matsumoto, H., Hotta, A., Itoh, T., et al. (2003). Journal of Bioscience and Bioengineering, 95, 231–238.
Huston, J. S., George, A. J. T., Adams, G. P., Stafford, W. F., Jamar, F., Tai, M., et al. (1996). The Quarterly Journal of Nuclear Medicine, 40, 320–333.
Yokota, T., Milenic, D. E., Whitlow, M., & Schlom, J. (1992). Cancer Research, 52, 3402–3408.
Reff, M. E., & Heard, C. (2001). Critical Reviews in Oncology/Hematology, 40, 25–35. doi:10.1016/S1040-8428(01)00132-9.
Cao, P., Zhang, S., Gong, Z., Tang, X., Cao, M., & Hu, Y. (2006). Applied Microbiology and Biotechnology, 73, 151–157. doi:10.1007/s00253-006-0432-4.
Jefferis, R. (2005). Biotechnology Progress, 21, 11–16. doi:10.1021/bp040016j.
Xiong, K. H., Liang, Q. C., Xiong, H., Zou, C. X., Gao, G. D., Zhao, Z. W., et al. (2005). Biotechnology Letters, 27, 1713–1717. doi:10.1007/s10529-005-2736-3.
Strutzenberger, K., Borth, N., Kunert, R., Steinfellner, W., & Katinger, H. (1999). Journal of Biotechnology, 69, 215–226. doi:10.1016/S0168-1656(99)00044-9.
Kim, S. J., & Lee, G. M. (1999). Biotechnology and Bioengineering, 64, 741–749. doi:10.1002/(SICI)1097-0290(19990920)64:6<741::AID-BIT14>3.0.CO;2-X.
Baker, K. P., Edwards, B. M., Main, S. H., Choi, G. H., Wager, R. E., Halpern, W. G., et al. (2003). Arthritis and Rheumatism, 48, 3253–3265. doi:10.1002/art.11299.
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., et al. (2002). Blood, 99, 754–758. doi:10.1182/blood.V99.3.754.
Acknowledgments
This work was supported by grants of the Nanjing Normal University and Jiangsu Province Graduate Innovation Project (No. 1612005024) and the International Cooperation of Jiangsu Province (No. BZ2007078). We are particularly grateful to Dr Ling Wang in Nanjing Medical University for help and technical support in the experiments of Flow Cytometry Analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, M., Cao, P., Yan, H. et al. Construction, Purification, and Characterization of Anti-BAFF scFv–Fc Fusion Antibody Expressed in CHO/dhfr− Cells. Appl Biochem Biotechnol 157, 562–574 (2009). https://doi.org/10.1007/s12010-008-8434-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-008-8434-6